INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
FDA Notification of FOI Expedite Request Denied Control # 2024-5142

FDA Notification of FOI Expedite Request Denied Control # 2024-5142

I have appealed to the Office of the Executive Secretariat, US Food & Drug Administration

Hedley Rees's avatar
Hedley Rees
Jun 21, 2024
∙ Paid
13

Share this post

INSIDE PHARMA
INSIDE PHARMA
FDA Notification of FOI Expedite Request Denied Control # 2024-5142
8
2
Share

The title is from an email from FDA earlier today:

Expedite Request Denied Control # 2024-5142

This is my appeal letter, just sent:

Office of the Executive Secretariat

US Food & Drug Administration

5630 Fishers Lane, Room 1050

Rockville, MD 20857

FDA FOIA reference file: 2024-5142

Dear Office of the Executive Secretariat,

I am in contact with Ms. Sly in relation to the FOIA reference above. The information provided was not initially as requested, but during a telephone conversation with Ms. Sly, June 17, 2024, I agreed to accept a previously released Establishment Inspection Report (EIR) for the CBER pre-license inspection ending July 23, 2021, at the Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC (used to support the original approval of COMRINATY, BLA 125742) in fulfillment of CBERs portion of my request.

The support I received from Ms. Sly was excellent. However, I was puzzled as to why the pre-license inspection above was not on the FDA inspections database, shown below (accessed 05…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share